Immunization, Vaccines and Biologicals

Professor Juhani Eskola

Director General - National Institute for Health and Welfare, Finland

Juhani Eskola is Director General at the National Institute for Health and Wellfare (THL), a governmental research institute and advisory body for the Ministry of Health. THL's functions are:

  • to promote the wellbeing and health of the population;
  • to prevent diseases and social problems
  • to develop social welfare and health care services.

Juhani Eskola graduated with a medical degree from the University of Helsinki in 1975, and received his PhD in medicine in 1983. He is a specialist in paediatric infectious diseases, a docent at the University of Helsinki and got the title of professor in 1996.

In the past, Eskola has worked as general practitioner, paediatrician and infectious disease specialist until 1991, and in 1991-1999 at the Finnish National Public Health Institute (KTL). In 1997-1998 he was Visiting Professor at Imperial College, London. During 2000-2003 Juhani Eskola worked as Senior Vice President at Aventis Pasteur (currently Sanofi Pasteur) in Lyon, France, being responsible for global medical affairs and clinical development of all vaccines in the Company. From 2004 on, Juhani Eskola has been back in Finland. He has worked as Deputy Director General of the Finnish Public Health Institute, KTL, where his responsibility areas were long term strategy and research activities in addition to control of infectious diseases and vaccinations, and during years 2009-2013 as Deputy Director General of THL.

Juhani Eskola has also served in several international development projects and initiatives as a consultant, evaluator or scientific adviser (e.g. in European Vaccine Initiative, EVI; European and Developing Countries Clinical Trial Partnership, EDCTP; and in the Tuberculosis Vaccine Initiative, TBVI) He is currently a member of the Board of Trustees of International Vaccine Institute, IVI. Eskola has been a member of the Strategic Advisory Group of Experts on Immunization, SAGE, since 2009.

Last updated: 26 March 2014